Humana Inc. (HUM) Position Lifted by UBS Asset Management Americas Inc.
UBS Asset Management Americas Inc. increased its stake in Humana Inc. (NYSE:HUM) by 68.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 772,771 shares of the insurance provider’s stock after buying an additional 314,086 shares during the period. UBS Asset Management Americas Inc. owned 0.53% of Humana worth $185,944,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. Acrospire Investment Management LLC purchased a new position in Humana in the 2nd quarter worth about $120,000. Independent Portfolio Consultants Inc. increased its stake in Humana by 22.1% in the 2nd quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in Humana by 139.5% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after buying an additional 325 shares during the period. Fiduciary Trust Co. purchased a new position in Humana in the 2nd quarter worth about $135,000. Finally, Guardian Life Insurance Co. of America increased its stake in Humana by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares during the period. 95.12% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION WARNING: “Humana Inc. (HUM) Position Lifted by UBS Asset Management Americas Inc.” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.thecerbatgem.com/2017/09/19/humana-inc-hum-position-lifted-by-ubs-asset-management-americas-inc.html.
HUM has been the topic of a number of research reports. Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, May 23rd. Leerink Swann raised their target price on shares of Humana from $250.00 to $265.00 and gave the company an “outperform” rating in a research report on Tuesday, May 30th. Royal Bank Of Canada reissued a “hold” rating and set a $214.00 target price on shares of Humana in a research report on Monday, June 5th. Morgan Stanley initiated coverage on shares of Humana in a research report on Tuesday, June 6th. They set an “overweight” rating and a $262.00 target price on the stock. Finally, Argus raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a research report on Friday, June 9th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $244.35.
Humana Inc. (NYSE:HUM) traded down 1.38% during mid-day trading on Tuesday, reaching $245.01. 332,082 shares of the company were exchanged. Humana Inc. has a 1-year low of $163.50 and a 1-year high of $259.76. The firm has a market capitalization of $35.41 billion, a P/E ratio of 20.16 and a beta of 0.87. The stock has a 50-day moving average of $250.69 and a 200 day moving average of $232.04.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The business had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same period in the prior year, the company earned $2.30 earnings per share. Equities research analysts forecast that Humana Inc. will post $11.55 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s payout ratio is currently 13.06%.
In other news, insider William Kevin Fleming sold 3,071 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total value of $770,759.58. Following the completion of the sale, the insider now directly owns 7,681 shares of the company’s stock, valued at $1,927,777.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP M Todoroff Christopher sold 22,935 shares of the stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $252.52, for a total value of $5,791,546.20. Following the completion of the sale, the vice president now directly owns 24,001 shares of the company’s stock, valued at $6,060,732.52. The disclosure for this sale can be found here. Insiders sold 60,566 shares of company stock valued at $15,326,746 over the last three months. Corporate insiders own 0.80% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.